Taki Chemical Co., Ltd. AI Stock Analysis
Want to see JP:4025 full AI Analyst Report?
Taki Chemical Co., Ltd. (4025) AI Stock Analysis
Taki Chemical Co., Ltd.
(TSE/TYO:4025)
The score is supported primarily by improving profitability and an exceptionally low-leverage balance sheet, which strengthen financial resilience. This is tempered by inconsistent cash-flow generation and currently weak technical momentum (below key short-term moving averages with negative MACD). Valuation is reasonable (P/E 12.64) but the dividend yield is modest (~1.17%).
Taki Chemical Co., Ltd. (4025) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 43.99B
- Dividend Yield
- 1.23%
- Average Volume (3M)
- 23.82K
- Price to Earnings (P/E)
- 11.4
- Beta (1Y)
- 0.74
- Revenue Growth
- 8.56%
- EPS Growth
- 38.01%
- Country
- Japan
- Employees
- 640
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Taki Chemical Co., Ltd. Business Overview & Revenue Model
Company Description
Taki Chemical Co., Ltd., founded in 1885 and headquartered in Kakogawa, Japan, is a diversified company operating in the agriculture, chemical, and real estate sectors. Formerly known as Taki Fertilizer Manufacturing Co., Ltd. until its name change i...
How the Company Makes Money
Taki Chemical Co., Ltd. generates revenue primarily by selling chemical products to corporate customers (B2B) under commercial supply agreements. Its earnings are driven by (1) product sales volume and mix across its chemical product lineup, (2) unit...
Taki Chemical Co., Ltd. Financial Statement Overview
Summary
Profitability has improved meaningfully (gross margin ~24.4% and net margin ~7.8% in 2025 vs. ~19.9% and ~3.9% in 2023) and the balance sheet is very conservatively financed (debt-to-equity ~0.03) with growing equity. Offsetting this, cash-flow quality is weaker with volatile free cash flow (negative in 2022–2023 and only ~¥0.75B in 2025) and uneven cash conversion versus net income.
Income Statement
76PositiveBalance Sheet
88Very PositiveCash Flow
58Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.89B | 41.98B | 38.92B | 34.85B | 35.85B | 32.81B |
| Gross Profit | 10.67B | 10.24B | 8.74B | 6.74B | 8.61B | 8.44B |
| EBITDA | 4.83B | 4.53B | 3.91B | 2.06B | 4.03B | 3.85B |
| Net Income | 3.42B | 3.28B | 2.30B | 1.36B | 2.06B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 68.41B | 65.65B | 58.40B | 51.30B | 50.32B | 46.04B |
| Cash, Cash Equivalents and Short-Term Investments | 6.98B | 7.37B | 7.46B | 5.08B | 6.26B | 6.53B |
| Total Debt | 1.27B | 1.26B | 1.22B | 1.15B | 1.24B | 1.34B |
| Total Liabilities | 23.02B | 22.32B | 20.44B | 17.40B | 18.26B | 16.66B |
| Stockholders Equity | 44.94B | 42.89B | 37.88B | 33.82B | 31.95B | 29.24B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 748.00M | 2.53B | -529.00M | -34.00M | 218.00M |
| Operating Cash Flow | 0 | 2.31B | 4.34B | 1.62B | 1.44B | 2.82B |
| Investing Cash Flow | 0 | -1.06B | -1.61B | -1.64B | -1.08B | -2.32B |
| Financing Cash Flow | 0 | -1.46B | -352.00M | -1.17B | -543.00M | -498.00M |
Taki Chemical Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4025, the sentiment is Negative. The current price of 5270.00 is below the 20-day moving average (MA) of 5443.00, below the 50-day MA of 5641.20, and above the 200-day MA of 4948.90, indicating a neutral trend. The MACD of -131.28 indicates Positive momentum. The RSI at 42.16 is Neutral, neither overbought nor oversold. The STOCH value of 59.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4025.
Taki Chemical Co., Ltd. Peers Comparison
Overall Rating
JP:501384Outperform
JP:446371Outperform
JP:402569Neutral
JP:496059Neutral
JP:436648Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | JPY 41.31B | 8.94 | ― | 3.82% | -0.92% | 0.66% | |
| 71Outperform | JPY 29.46B | 7.77 | ― | 3.46% | 10.62% | 52.17% | |
| 69Neutral | JPY 45.86B | 11.38 | ― | 1.23% | 8.56% | 38.01% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 59Neutral | JPY 8.07B | 20.98 | ― | 1.02% | 6.87% | 300.65% | |
| 48Neutral | JPY 14.38B | 11.80 | ― | 1.88% | 10.12% | 43.23% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4025 | Taki Chemical Co., Ltd. | 5270.00 | 1766.77 | 50.43% | |
| JP:4366 | Daito Chemix Corporation | 426.00 | 166.39 | 64.10% | |
| JP:4463 | Nicca Chemical Co., Ltd. | 1881.00 | 448.04 | 31.27% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 488.00 | 164.43 | 50.82% | |
| JP:5013 | Yushiro Chemical Industry Co., Ltd. | 3195.00 | 1014.39 | 46.52% |
Taki Chemical Co., Ltd. Corporate Events
Taki Chemical Reports Higher Nine-Month Revenue and Profit
Taki Chemical Co., Ltd. is a Tokyo-listed chemical company, although the release does not specify its primary products or market focus. For the nine months ended September 30, 2026, revenue rose 9.5% year on year to ¥33.05 billion, while operating pr...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 23, 2026
